P and T最新文献

筛选
英文 中文
Reversal of Dabigatran Bleeding and Coagulopathy Using Idarucizumab in a Patient With Acute Kidney Injury. 使用伊达珠单抗逆转急性肾损伤患者的达比加群出血和凝血功能障碍
P and T Pub Date : 2018-12-01
Jennifer Vidal, Richard DePalma, Leila Forouzan
{"title":"Reversal of Dabigatran Bleeding and Coagulopathy Using Idarucizumab in a Patient With Acute Kidney Injury.","authors":"Jennifer Vidal, Richard DePalma, Leila Forouzan","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Idarucizumab is approved for patients treated with dabigatran when reversal of the anticoagulant effects is needed. Like dabigatran, idarucizumab is excreted in the urine. The effect of renal dysfunction on drug elimination is uncertain, as patients in the RE-VERSE AD trial had a median creatinine clearance of 58 mL/min. Also, dabigatran accumulation can occur if the international normalized ratio (INR) is greater than two. A 73-year-old female was admitted for lower extremity edema and increased abdominal girth. On admission, the patient was in acute kidney injury (AKI) with an estimated creatinine clearance of 34.5 mL/min. Her prothrombin time (PT) on admission was 17 seconds, her INR was 1.4, and her hemoglobin was 8.7 gm/dL (12-16 gm/dL). Throughout her admission, she was continued on her home regimen of dabigatran 150 mg twice daily for atrial fibrillation. On day 4, she had rectal bleeding and altered mental status. At this time, her PT was elevated to 25.6 seconds, her INR had increased to 2.3, and her hemoglobin had dropped to 6.8 gm/dL. Two doses of idarucizumab 2.5 gm were administered, and dabigatran was successfully reversed with cessation of bleeding and normalization of the INR to 1.5. An additional dose of idarucizumab was not required. The patient was discharged home two days later. Idarucizumab successfully reversed the bleeding and coagulopathy associated with dabigatran in a patient with AKI.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"43 12","pages":"748-749"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281148/pdf/ptj4312748.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36780983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Partially Filled Vials and Syringes in Sharps Containers Are a Key Source of Drug Diversion. 部分灌装的小瓶和注射器是药品转移的主要来源。
P and T Pub Date : 2018-12-01
Matthew Grissinger
{"title":"Partially Filled Vials and Syringes in Sharps Containers Are a Key Source of Drug Diversion.","authors":"Matthew Grissinger","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Leftover or improperly discarded drugs are easy prey for diversion and are fueling the opioid abuse epidemic. ISMP offers safe practice recommendations to prevent drug misuse.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"43 12","pages":"714-717"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281145/pdf/ptj4312714.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36780976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Extraordinary Importance of Sleep: The Detrimental Effects of Inadequate Sleep on Health and Public Safety Drive an Explosion of Sleep Research. 睡眠的非凡重要性:睡眠不足对健康和公共安全的有害影响推动了睡眠研究的爆炸式增长。
P and T Pub Date : 2018-12-01
Susan L Worley
{"title":"The Extraordinary Importance of Sleep: The Detrimental Effects of Inadequate Sleep on Health and Public Safety Drive an Explosion of Sleep Research.","authors":"Susan L Worley","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>New sleep deprivation studies confirm the relationship between inadequate sleep and a wide range of disorders, such as hypertension, obesity and type-2 diabetes, cardiovascular disease, impaired immune functioning, and more.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"43 12","pages":"758-763"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281147/pdf/ptj4312758.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36780985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmaceutical Approval Update. 药品审批更新。
P and T Pub Date : 2018-12-01
Michele B Kaufman
{"title":"Pharmaceutical Approval Update.","authors":"Michele B Kaufman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Mulpleta (lusutrombopag) for thrombocytopenia; ajovy (fremenezumab-vfrm) for migraine; takhzyro (lanadelumab-flyo) for hereditary angioedema attacks.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"43 12","pages":"734-735"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281146/pdf/ptj4312734.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36780979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Care Price Transparency Initiatives Are All the Rage: But Burgeoning Efforts Suffer from Myriad Shortcomings. 医疗保健价格透明倡议风靡一时:但新兴的努力遭受了无数的缺点。
P and T Pub Date : 2018-12-01
Stephen Barlas
{"title":"Health Care Price Transparency Initiatives Are All the Rage: But Burgeoning Efforts Suffer from Myriad Shortcomings.","authors":"Stephen Barlas","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Americans worry more about the cost and availability of health care than any other major societal issue. Clarity in treatment costs could help alleviate stress.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"43 12","pages":"744-768"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281149/pdf/ptj4312744.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36780981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ertugliflozin (Steglatro): A New Option for SGLT2 Inhibition. 埃图格列净(Steglatro):抑制SGLT2的新选择。
P and T Pub Date : 2018-12-01
Nikolas Kovacich, Benjamin Chavez
{"title":"Ertugliflozin (Steglatro): A New Option for SGLT2 Inhibition.","authors":"Nikolas Kovacich,&nbsp;Benjamin Chavez","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Steglatro (ertugliflozin) for glycemic control in adults with type-2 diabetes mellitus.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"43 12","pages":"736-742"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281144/pdf/ptj4312736.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36780980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promising Multiple Sclerosis Agents In Late-Stage Development. 晚期多发性硬化症药物发展前景看好。
P and T Pub Date : 2018-12-01
Troy Kish
{"title":"Promising Multiple Sclerosis Agents In Late-Stage Development.","authors":"Troy Kish","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Developing drugs with enhanced safety profiles and improving treatment affordability are vital for patients with MS. The author reviews some encouraging new agents in late-stage development.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"43 12","pages":"750-772"},"PeriodicalIF":0.0,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281141/pdf/ptj4312750.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36780984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research Briefs. 研究简报。
P and T Pub Date : 2018-11-01
{"title":"Research Briefs.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":38773,"journal":{"name":"P and T","volume":"43 11","pages":"696-700"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205118/pdf/ptj43011696.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36659733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2018 European Association for the Study of Diabetes. 2018年欧洲糖尿病研究协会。
P and T Pub Date : 2018-11-01
Walter Alexander
{"title":"2018 European Association for the Study of Diabetes.","authors":"Walter Alexander","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We review sessions on the association of diuretic use and amputations, albiglutide and cardiovascular outcomes with diabetes and cardiovascular disease, how lorcaserin affects diabetes in overweight patients, how testosterone therapy improves diabetes in hypogonadal men, the pros and cons of gastric bypass surgery, how low-calorie sweeteners affect the gut microbiome, and more.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"43 11","pages":"689-693"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205117/pdf/ptj43011689.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36659734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selected Medication Safety Risks That Can Easily Fall Off the Radar Screen-Part 3. 一些很容易被忽视的药物安全风险——第三部分。
P and T Pub Date : 2018-11-01
Matthew Grissinger
{"title":"Selected Medication Safety Risks That Can Easily Fall Off the Radar Screen-Part 3.","authors":"Matthew Grissinger","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The final part of a 3-part series discusses medication safety risks related to labeling, patient education, and medication storage.</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"43 11","pages":"645-666"},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205125/pdf/ptj43011645.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36708464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信